Hexo Corp
TSX:HEXO

Watchlist Manager
Hexo Corp Logo
Hexo Corp
TSX:HEXO
Watchlist
Price: 0.88 CAD 1.15% Market Closed
Market Cap: 38.7m CAD

EV/EBITDA
Enterprise Value to EBITDA

-1.9
Current
-1.9
Median
13.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.9
=
Enterprise Value
197.8m CAD
/
EBITDA
-102.7m CAD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
CA
Hexo Corp
TSX:HEXO
Average EV/EBITDA: 439.1
Negative Multiple: -1.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.1
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
109.1
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.7
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-45.1
2-Years Forward
EV/EBITDA
25.9
3-Years Forward
EV/EBITDA
13.5